| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 544,064 | 544,037 | 551,155 | 626,250 | | Cost of Revenue | 407,572 | 410,043 | 427,490 | 486,522 | | | Gross Profit | 136,492 | 133,994 | 123,665 | 139,728 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 90,660 | 86,659 | 86,228 | 97,906 | | Non Recurring |
-
|
-
|
-
| 245,700 | | Others | 3,156 | 3,256 | 3,056 | 2,306 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 42,676 | 44,079 | 34,381 | (206,184) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,878 | 2,920 | 8,945 | (6,368) | | Earnings Before Interest And Taxes | 44,554 | 46,999 | 43,326 | (212,552) | | Interest Expense | 23,172 | 21,385 | 21,644 | 23,607 | | Income Before Tax | 21,382 | 25,614 | 21,682 | (236,159) | | Income Tax Expense | 7,582 | 9,666 | 8,654 | (14,155) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 13,800 | 15,948 | 13,028 | (222,004) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 13,800 | 15,948 | 13,028 | (222,004) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $13,800 | $15,948 | $13,028 | ($222,004) |
|
0.02% Nasdaq 
Income Statement
